×
About 230,292 results

ALLMedicine™ Lung Cancer Center

Research & Reviews  106,477 results

Radiomics for prediction of radiation-induced lung injury and oncologic outcome after r...
https://doi.org/10.1186/s13014-021-01805-6 10.1016/j.jtcvs.2018.09.107 10.1007/s00066-013-0450-y 10.1016/j.radonc.2017.05.012 10.1148/rg.2018170155 10.1016/j.radonc.2015.09.008 10.1016/j.ijrobp.2012.09.016 10.1259/bjr.20160508 10.1016/j.ijrobp.2016.03.024 10.1093/jrr/rrv019 10.1080/02841860802520821 10.3389/fonc.2018.00171 10.21037/jtd.2018.12.115 10.1038/ncomms5006 10.1016/j.jtho.2016.11.2226 10.1016/j.radonc.2016.04.004 10.1016/j.radonc.2015.02.015 10.1371/journal.pone.0118261 10.1016/j.ejrad.2016.09.005 10.1038/s41598-019-53461-2 10.1016/j.radonc.2016.05.024 10.1371/journal.pone.0169172 10.1088/1361-6560/aaf5a5 10.1016/j.radonc.2018.06.025 10.1002/mp.12309 10.1186/s13014-017-0892-y 10.1016/j.media.2018.09.004 10.1038/s41598-018-22357-y 10.1259/bjr.20180228 10.1371/journal.pone.0217536 10.1007/s00066-019-01452-7 10.1007/s00066-020-01583-2 10.1007/s00066-017-1204-z 10.1007/s00066-017-1194-x 10.1007/s00066-018-1416-x 10.1097/JTO.0b013e318219aac5 10.1016/j.lungcan.2009.09.006 10.1158/0008-5472.CAN-17-0339 10.1002/bimj.200900064 10.1016/j.ijrobp.2006.08.058 10.1016/j.ijrobp.2017.03.011 10.7554/eLife.23421 10.1038/s41598-018-20471-5 10.3389/fonc.2019.00269 10.1088/1361-6560/aabb5e 10.1016/S2589-7500(19)30058-5 10.1038/s41598-021-85671-y 10.1038/s41598-020-70542-9 10.1038/srep46349
Radiation Oncology (London, England); Bousabarah K, Blanck O et. al.

Apr 17th, 2021 - To generate and validate state-of-the-art radiomics models for prediction of radiation-induced lung injury and oncologic outcome in non-small cell lung cancer (NSCLC) patients treated with robotic stereotactic body radiation therapy (SBRT). Radiom...

Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Pati...
https://doi.org/10.1016/j.clon.2021.03.019
Clinical Oncology (Royal College of Radiologists (Great B... Punjabi A, Barrett E et. al.

Apr 17th, 2021 - The neutrophil-lymphocyte ratio (NLR) and the absolute lymphocyte count (ALC) have been proposed as prognostic markers in non-small cell lung cancer (NSCLC). The objective of this study was to examine the association of NLR/ALC before and after cu...

Rare case of primary small-cell neuroendocrine breast carcinoma.
https://doi.org/10.1136/bcr-2020-237474
BMJ Case Reports; Pankratjevaite L, Holmqvist M et. al.

Apr 17th, 2021 - Small-cell breast cancer is a very rare and aggressive type of neuroendocrine carcinoma. Histologically, it is indistinguishable from small-cell neuroendocrine lung cancer. Due to that, patients with small-cell neuroendocrine breast cancer should ...

Mechanisms exploration of Xiaojin Pills on lung cancer based on metabolomics and networ...
https://doi.org/10.1093/jpp/rgab050
The Journal of Pharmacy and Pharmacology; Cao B, Lin J et. al.

Apr 17th, 2021 - This study was designed to evaluate the pharmacological activity and therapeutic mechanism of Xiaojin Pills (XJW) on lung cancer. Mice were orally administered with Xiaojin Pills for 21 days. Tumour samples were collected to evaluate the antilung ...

SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer.
https://doi.org/10.1038/s41467-021-22480-x 10.1073/pnas.89.21.10405 10.1038/ncomms4446 10.1016/j.freeradbiomed.2009.05.018 10.1016/j.drudis.2015.10.001 10.1073/pnas.0709451105 10.1016/j.cell.2012.11.046 10.1172/JCI71714 10.1038/s41388-019-0839-x 10.1074/jbc.C113.526475 10.1073/pnas.1113554108 10.1016/j.molcel.2018.03.029 10.1038/nrdp.2015.9 10.1038/nature13385 10.1158/1078-0432.CCR-06-0171 10.1038/35030140 10.1016/j.freeradbiomed.2013.02.003 10.1158/2159-8290.CD-14-0363 10.1096/fj.13-228130 10.1016/j.stem.2007.03.002 10.1073/pnas.91.17.8292 10.21037/jtd.2017.12.61 10.1101/gad.13.1.76 10.1016/j.cbi.2013.12.005 10.1038/sj.emboj.7600276 10.1146/annurev.biochem.72.121801.161647 10.1093/hmg/8.8.1451 10.1016/j.molcel.2004.05.020 10.1083/jcb.200501141 10.1016/j.biocel.2018.08.014 10.1002/gcc.20351 10.1038/nmeth.f.351 10.1128/MCB.00172-07 10.1002/wrna.1269 10.1128/MCB.20.15.5516-5528.2000 10.1093/nar/gku787 10.1007/978-1-4939-3792-9_12 10.1146/annurev-biochem-013118-110817 10.1126/science.aan2755 10.2353/ajpath.2008.070752 10.1111/j.1365-2559.2008.03168.x 10.1083/jcb.200501141 10.1093/nar/gkl378 10.2147/CMAR.S176268 10.1038/nrc.2017.104 10.1038/ng0597-19 10.1038/nprot.2009.95 10.1016/j.ccell.2014.09.008 10.1016/j.celrep.2015.03.040 10.1002/hep.29715 10.1016/S0968-4328(99)00069-4 10.1038/nprot.2006.179 10.1038/nature05020 10.1038/sj.emboj.7601488 10.1074/jbc.M109.031302 10.1038/emboj.2009.179
Nature Communications; Wang X, Zhang H et. al.

Apr 16th, 2021 - SOD1 is known as the major cytoplasmic superoxide dismutase and an anticancer target. However, the role of SOD1 in cancer is not fully understood. Herein we describe the generation of an inducible Sod1 knockout in KRAS-driven NSCLC mouse model. So...

see more →

Guidelines  639 results

Staged management of cardiac disease and concomitant early lung cancer: a 20-year single-center experience
https://pubmed.ncbi.nlm.nih.gov/33210113/
European Journal of Cardio-Thoracic Surgery; Tricard J

Apr 12th, 2021 - The association of unstable heart disease and resectable lung cancer is rare. The impacts of staged management, cardiac surgery with cardiopulmonary bypass (CPB) versus angioplasty, on long-term survival and cancer recurrence remain debated. We re...

Sensations, symptoms, and then what? Early bodily experiences prior to diagnosis of lung cancer
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0249114
PLoS One; Bernhardson BM

Mar 28th, 2021 - Lung cancer (LC) generally lacks unique core symptoms or signs. However, there are a multitude of bodily sensations that are often non-specific, not easily understood, and many times initially not recognized as indicative of LC by the affected per...

The Aging Lung: Physiology, disease, and immunity
https://pubmed.ncbi.nlm.nih.gov/33811810/
Cell Schneider JL

Mar 25th, 2021 - The population is aging at a rate never seen before in human history. As the number of elderly adults grows, it is imperative we expand our understanding of the underpinnings of aging biology. Human lungs are composed of a unique panoply of cell t...

Prophylactic cranial irradiation for extensive‐stage small cell lung cancer
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014559/full
Cochrane Database of Systematic Reviews; Nishie K

Mar 17th, 2021 - To assess the effectiveness and safety of PCI plus standard treatment compared to standard treatment alone in people with ED‐SCLC who have responded to first‐line chemotherapy.

Metformin improves survival in patients with concurrent diabetes and small cell lung cancer: a meta-analysis
https://pubmed.ncbi.nlm.nih.gov/33759443/
Minerva Endocrinology; Fan H, et ak

Mar 15th, 2021 - To compare survival outcome among the patients with concurrent small cell lung cancer (SCLC) and diabetes mellitus (DM) using metformin or without metformin.

see more →

Drugs  389 results see all →

Clinicaltrials.gov  115,427 results

Radiomics for prediction of radiation-induced lung injury and oncologic outcome after r...
https://doi.org/10.1186/s13014-021-01805-6 10.1016/j.jtcvs.2018.09.107 10.1007/s00066-013-0450-y 10.1016/j.radonc.2017.05.012 10.1148/rg.2018170155 10.1016/j.radonc.2015.09.008 10.1016/j.ijrobp.2012.09.016 10.1259/bjr.20160508 10.1016/j.ijrobp.2016.03.024 10.1093/jrr/rrv019 10.1080/02841860802520821 10.3389/fonc.2018.00171 10.21037/jtd.2018.12.115 10.1038/ncomms5006 10.1016/j.jtho.2016.11.2226 10.1016/j.radonc.2016.04.004 10.1016/j.radonc.2015.02.015 10.1371/journal.pone.0118261 10.1016/j.ejrad.2016.09.005 10.1038/s41598-019-53461-2 10.1016/j.radonc.2016.05.024 10.1371/journal.pone.0169172 10.1088/1361-6560/aaf5a5 10.1016/j.radonc.2018.06.025 10.1002/mp.12309 10.1186/s13014-017-0892-y 10.1016/j.media.2018.09.004 10.1038/s41598-018-22357-y 10.1259/bjr.20180228 10.1371/journal.pone.0217536 10.1007/s00066-019-01452-7 10.1007/s00066-020-01583-2 10.1007/s00066-017-1204-z 10.1007/s00066-017-1194-x 10.1007/s00066-018-1416-x 10.1097/JTO.0b013e318219aac5 10.1016/j.lungcan.2009.09.006 10.1158/0008-5472.CAN-17-0339 10.1002/bimj.200900064 10.1016/j.ijrobp.2006.08.058 10.1016/j.ijrobp.2017.03.011 10.7554/eLife.23421 10.1038/s41598-018-20471-5 10.3389/fonc.2019.00269 10.1088/1361-6560/aabb5e 10.1016/S2589-7500(19)30058-5 10.1038/s41598-021-85671-y 10.1038/s41598-020-70542-9 10.1038/srep46349
Radiation Oncology (London, England); Bousabarah K, Blanck O et. al.

Apr 17th, 2021 - To generate and validate state-of-the-art radiomics models for prediction of radiation-induced lung injury and oncologic outcome in non-small cell lung cancer (NSCLC) patients treated with robotic stereotactic body radiation therapy (SBRT). Radiom...

Neutrophil-Lymphocyte Ratio and Absolute Lymphocyte Count as Prognostic Markers in Pati...
https://doi.org/10.1016/j.clon.2021.03.019
Clinical Oncology (Royal College of Radiologists (Great B... Punjabi A, Barrett E et. al.

Apr 17th, 2021 - The neutrophil-lymphocyte ratio (NLR) and the absolute lymphocyte count (ALC) have been proposed as prognostic markers in non-small cell lung cancer (NSCLC). The objective of this study was to examine the association of NLR/ALC before and after cu...

Rare case of primary small-cell neuroendocrine breast carcinoma.
https://doi.org/10.1136/bcr-2020-237474
BMJ Case Reports; Pankratjevaite L, Holmqvist M et. al.

Apr 17th, 2021 - Small-cell breast cancer is a very rare and aggressive type of neuroendocrine carcinoma. Histologically, it is indistinguishable from small-cell neuroendocrine lung cancer. Due to that, patients with small-cell neuroendocrine breast cancer should ...

Mechanisms exploration of Xiaojin Pills on lung cancer based on metabolomics and networ...
https://doi.org/10.1093/jpp/rgab050
The Journal of Pharmacy and Pharmacology; Cao B, Lin J et. al.

Apr 17th, 2021 - This study was designed to evaluate the pharmacological activity and therapeutic mechanism of Xiaojin Pills (XJW) on lung cancer. Mice were orally administered with Xiaojin Pills for 21 days. Tumour samples were collected to evaluate the antilung ...

SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer.
https://doi.org/10.1038/s41467-021-22480-x 10.1073/pnas.89.21.10405 10.1038/ncomms4446 10.1016/j.freeradbiomed.2009.05.018 10.1016/j.drudis.2015.10.001 10.1073/pnas.0709451105 10.1016/j.cell.2012.11.046 10.1172/JCI71714 10.1038/s41388-019-0839-x 10.1074/jbc.C113.526475 10.1073/pnas.1113554108 10.1016/j.molcel.2018.03.029 10.1038/nrdp.2015.9 10.1038/nature13385 10.1158/1078-0432.CCR-06-0171 10.1038/35030140 10.1016/j.freeradbiomed.2013.02.003 10.1158/2159-8290.CD-14-0363 10.1096/fj.13-228130 10.1016/j.stem.2007.03.002 10.1073/pnas.91.17.8292 10.21037/jtd.2017.12.61 10.1101/gad.13.1.76 10.1016/j.cbi.2013.12.005 10.1038/sj.emboj.7600276 10.1146/annurev.biochem.72.121801.161647 10.1093/hmg/8.8.1451 10.1016/j.molcel.2004.05.020 10.1083/jcb.200501141 10.1016/j.biocel.2018.08.014 10.1002/gcc.20351 10.1038/nmeth.f.351 10.1128/MCB.00172-07 10.1002/wrna.1269 10.1128/MCB.20.15.5516-5528.2000 10.1093/nar/gku787 10.1007/978-1-4939-3792-9_12 10.1146/annurev-biochem-013118-110817 10.1126/science.aan2755 10.2353/ajpath.2008.070752 10.1111/j.1365-2559.2008.03168.x 10.1083/jcb.200501141 10.1093/nar/gkl378 10.2147/CMAR.S176268 10.1038/nrc.2017.104 10.1038/ng0597-19 10.1038/nprot.2009.95 10.1016/j.ccell.2014.09.008 10.1016/j.celrep.2015.03.040 10.1002/hep.29715 10.1016/S0968-4328(99)00069-4 10.1038/nprot.2006.179 10.1038/nature05020 10.1038/sj.emboj.7601488 10.1074/jbc.M109.031302 10.1038/emboj.2009.179
Nature Communications; Wang X, Zhang H et. al.

Apr 16th, 2021 - SOD1 is known as the major cytoplasmic superoxide dismutase and an anticancer target. However, the role of SOD1 in cancer is not fully understood. Herein we describe the generation of an inducible Sod1 knockout in KRAS-driven NSCLC mouse model. So...

see more →

News  7,257 results

Neutrophil/Lymphocyte Ratio May Be Tied to Survival in Patients Receiving Immunotherapy for NSCLC Brain Metastases
https://www.medscape.com/viewarticle/949326

Apr 15th, 2021 - NEW YORK (Reuters Health) - In patients with non-small cell lung cancer brain metastases (NSCLCBM) treated with immune-checkpoint inhibitors (ICIs) and upfront steroids, a low neutrophil-to-lymphocyte ratio (NLR) was associated with lower overall ...

Rankings of Most Common Cancers to Shift Over Next 20 Years
https://www.medscape.com/viewarticle/949253

Apr 13th, 2021 - The next 20 years will see a big shift in cancer type rankings, researchers predict. At the moment, the most common cancers in the United States are breast, lung, prostate, colorectal, and melanoma. By 2040, melanoma will have become the second mo...

Leading Oncologist's 'Over-Optimistic' Treatment for Advanced Cancer Patient
https://www.medscape.com/viewarticle/949161

Apr 12th, 2021 - Editor's note, 13 April 2021: This article was updated with coverage of Tuesday's evidence. MANCHESTER—Leading oncologist Professor Justin Stebbing gave chemotherapy to a patient in the "over-optimistic" belief he could reverse her advanced and ag...

Staged management of cardiac disease and concomitant early lung cancer: a 20-year single-center experience
https://pubmed.ncbi.nlm.nih.gov/33210113/
European Journal of Cardio-Thoracic Surgery; Tricard J

Apr 12th, 2021 - The association of unstable heart disease and resectable lung cancer is rare. The impacts of staged management, cardiac surgery with cardiopulmonary bypass (CPB) versus angioplasty, on long-term survival and cancer recurrence remain debated. We re...

Presurgical Nivo/Chemo Boosts pCR Rates in NSCLC
https://www.medscape.com/viewarticle/949093

Apr 11th, 2021 - Patients with resectable non–small cell lung cancer (NSCLC) often receive treatment before they undergo surgery. For such patients who achieve a pathologic complete response (pCR), the chances of survival are improved. However, only a small percen...

see more →

Patient Education  103 results see all →